Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 09:44 am Sale |
2020-12-31 | 13G | Telesis Bio, Inc. TBIO |
RTW Investments, LP | 165,468 4.010% |
-18,132 (-9.88%) |
Filing History |
| 2021-02-12 09:42 am Unchanged |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,463,601 12.130% |
0 (Unchanged) |
Filing History |
| 2021-02-12 09:40 am Unchanged |
2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 3,544,248 9.890% |
0 (Unchanged) |
Filing History |
| 2021-02-12 09:39 am Purchase |
2020-12-31 | 13G | BrainsWay Ltd. BWAY |
RTW Investments, LP | 2,206,948 9.920% |
290,096 (+15.13%) |
Filing History |
| 2021-02-12 09:38 am Purchase |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 1,512,673 9.310% |
256,816 (+20.45%) |
Filing History |
| 2021-02-12 09:37 am Purchase |
2020-12-31 | 13G | BELLUS Health Inc. BLU |
RTW Investments, LP | 5,189,862 6.620% |
348,870 (+7.21%) |
Filing History |
| 2021-02-12 09:36 am Purchase |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 3,650,069 8.670% |
1,190,081 (+48.38%) |
Filing History |
| 2021-02-12 09:34 am Purchase |
2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW Investments, LP | 5,387,513 9.260% |
1,986,079 (+58.39%) |
Filing History |
| 2021-02-12 09:34 am Purchase |
2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 4,221,836 6.190% |
389,356 (+10.16%) |
Filing History |
| 2021-02-12 09:32 am Purchase |
2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 5,009,768 9.260% |
230,633 (+4.83%) |
Filing History |
| 2021-02-12 09:31 am Purchase |
2020-12-31 | 13G | Athira Pharma, Inc. ATHA |
RTW Investments, LP | 2,685,779 8.260% |
16,866 (+0.63%) |
Filing History |
| 2021-02-12 09:30 am Purchase |
2020-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
RTW Investments, LP | 1,925,594 7.450% |
10,988 (+0.57%) |
Filing History |
| 2021-02-12 09:28 am Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RTW Investments, LP | 4,315,201 14.460% |
356,937 (+9.02%) |
Filing History |
| 2021-02-12 09:28 am Unchanged |
2020-12-31 | 13G | Apyx Medical Corporation APYX |
RTW Investments, LP | 3,391,279 9.890% |
0 (Unchanged) |
Filing History |
| 2021-02-12 09:26 am Sale |
2020-12-31 | 13G | La Jolla Pharmaceutical Company LJPC |
RTW Investments, LP | 2,397,378 8.750% |
-153,642 (-6.02%) |
Filing History |
| 2021-02-12 09:25 am Sale |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW Investments, LP | 177 6.960% |
-1 (-0.61%) |
Filing History |
| 2021-02-12 09:23 am Purchase |
2020-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
RTW Investments, LP | 5,978,355 7.050% |
311,601 (+5.50%) |
Filing History |
| 2021-02-12 09:21 am Sale |
2020-12-31 | 13G | Agenus Inc. AGEN |
RTW Investments, LP | 655,455 6.760% |
-43,846 (-6.27%) |
Filing History |
| 2021-02-12 09:17 am Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
RTW Investments, LP | 722,736 7.420% |
84,076 (+13.16%) |
Filing History |
| 2021-02-04 12:36 pm Purchase |
2021-01-25 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 2,762,791 7.880% |
2,762,791 (New Position) |
Filing History |